Evidence map›Paper›PMID 32398371›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Kyle N Goodman, Matthew J Powers, Alexander A Crofts, M Stephen Trent, David R Hendrixson

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. AProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. ThemBio · 2025
    Article
  5. Therapeutic and protective approaches to combatFrontiers in pharmacology · 2025
    Review
  6. Review
  7. Gut metabolite L-lactate supportsProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Two-component regulatory systems inFrontiers in cellular and infection microbiology · 2022
    Review
  10. Review
  11. Review
  12. The DegU Orphan Response Regulator Contributes to Heat Stress Resistance inFrontiers in cellular and infection microbiology · 2021
    Article
  13. Long-Term Grow-Out AffectsFrontiers in veterinary science · 2021
    Article
  14. Campylobacter Virulence Factors and Molecular Host-Pathogen Interactions.Current topics in microbiology and immunology · 2021
    Review
  15. Article
  16. RevisitingFrontiers in cellular and infection microbiology · 2020
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kyle N GoodmanDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-6428-5813
Matthew J PowersDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.
Alexander A CroftsDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.
M Stephen TrentDepartment of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.ORCID 0000-0001-6134-1800
David R HendrixsonDepartment of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX 75390; david.hendrixson@utsouthwestern.edu.ORCID 0000-0001-8496-2466
University of Georgia · USThe University of Texas Southwestern Medical Center · US

Funding

Flagellar Motor Biogenesis in Polarly-Flagellated Bacterial PathogensR01AI065539 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI DAVID R HENDRIXSON · 2006 to 2026
$9.2M
MOLECULAR MICROBIOLOGY TRAINING GRANTT32AI007520 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Julie K Pfeiffer · 1997 to 2026
$7.0M
The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumanniiR01AI150098 · NIAID · UNIVERSITY OF GEORGIA · PI Michael Stephen Trent · 2020 to 2026
$3.9M
Development of a novel vaccine platform: Surface Antigen/Adjuvant Vaccine Engineering (SAAVE)R01AI129940 · NIAID · UNIVERSITY OF GEORGIA · PI TRENT, MICHAEL STEPHEN · 2017 to 2021
$3.3M
Impact of Microbiota-Generated Metabolites on Campylobacter jejuni ColonizationR01HD095830 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · PI HENDRIXSON, DAVID R · 2019 to 2023
$2.3M
Molecular mechanisms required for the maintenance of the gram-negative outer membraneR01AI138576 · NIAID · UNIVERSITY OF GEORGIA · PI TRENT, MICHAEL STEPHEN · 2018 to 2022
$2.0M
NIAID NIH HHS R01 AI065539NIAID NIH HHS R01 AI129940NIAID NIH HHS R01 AI138576NIAID NIH HHS R01 AI150098NIAID NIH HHS T32 AI007520NICHD NIH HHS R01 HD095830
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacterial ProteinsCampylobacter jejuniAnimalsButyratesCampylobacter InfectionsChickensGene Expression Regulation, BacterialHumansPhosphoric Monoester HydrolasesSignal TransductionBacterial ProteinsButyratesPhosphoric Monoester HydrolasesBumSbutyrateCampylobacter jejunishort-chain fatty acidstwo-component signal transduction system

Identifiers

PMID32398371
PMCPMC7260946
OpenAlexW3024945429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.